Related Experiment Video
Updated: Apr 26, 2026
09:18
Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
Published on: February 3, 2026
1.0K
KRAS in pancreatic cancer
Archana Agarwal1, Muhammad Wasif Saif
1Department of Medicine, Steward Carney Hospital. Boston, MA, USA. archana.agarwal@steward.org.
JOP : Journal of the Pancreas
|July 31, 2014
Summary
This review explores KRAS mutations in pancreatic cancer, finding a low mutation rate in ascitic fluid. These insights into KRAS and wild-type tumors advance understanding and treatment of this malignancy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Pancreatic cancer, primarily ductal adenocarcinoma, frequently harbors KRAS oncogene mutations.
- Directly targeting KRAS remains challenging, with limited understanding of its interactions with other signaling pathways.
- Knowledge gaps exist regarding non-KRAS mutated (wild-type) tumors and mutational status in metastatic lesions.
Purpose of the Study:
- To review findings on the relationship between KRAS and other signaling pathways in pancreatic cancer.
- To discuss differences between KRAS-mutated and wild-type pancreatic tumors.
- To highlight novel findings regarding KRAS mutational status in metastatic pancreatic cancer cells.
Main Methods:
- Review of two abstracts (e15214 and e15207) presented at the 2014 ASCO Annual Meeting.
- Analysis of studies examining KRAS mutational status in pancreatic tumors and metastatic lesions (ascitic fluid).
- Discussion of signaling pathway interactions and tumor heterogeneity.
Main Results:
- Low rates of KRAS mutations were observed in cells derived from ascitic fluid.
- The abstracts provided insights into the differences between KRAS-mutated and wild-type pancreatic tumors.
- Data suggests potential differences in mutational status between primary tumors and metastatic sites.
Conclusions:
- The findings on KRAS mutation rates in ascitic fluid are novel and warrant further investigation.
- These studies contribute to a better understanding of pancreatic cancer biology.
- Exploring these differences may lead to improved therapeutic strategies for pancreatic cancer.
More Related Videos
07:08Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
1.7K
06:57Utilizing High Resolution Ultrasound to Monitor Tumor Onset and Growth in Genetically Engineered Pancreatic Cancer Models
Published on: April 7, 2018
10.5K
Related Concept Videos
01:24Chronic Pancreatitis I: Introduction
903
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
903
01:25Chronic Pancreatitis I: Introduction
24
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
24
01:25Acute Pancreatitis I: Introduction
19
Acute pancreatitis is the sudden inflammation of the pancreas caused by the early activation of digestive enzymes, leading to the autodigestion of pancreatic tissue. This results in local inflammation and, in severe cases, systemic complications.EtiologyUnderstanding the underlying causes is crucial, as identifying the etiology guides treatment and anticipates complications. Acute pancreatitis can be triggered by various factors, typically grouped into the following clinical categories.Biliary...
19
01:21Acute Pancreatitis II: Pathophysiology
40
The pathophysiology of acute pancreatitis centers on injury to pancreatic acinar cells, which initiates a cascade of harmful intracellular events.This injury leads to premature activation of trypsinogen to trypsin in the pancreas. Trypsin then activates other digestive enzymes, such as chymotrypsin, elastase, and phospholipase A2, which begin breaking down pancreatic tissue. The resulting autodigestion causes local inflammation, tissue swelling, hemorrhage, and fat necrosis.Injured acinar cells...
40
01:21Chronic Pancreatitis II: Pathophysiology
24
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
24